What is the ticker symbol for Graphite Bio?

Graphite Bio trades under the ticker GRPH on NASDAQ.

What sector does Graphite Bio operate in?

Graphite Bio is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze GRPH in a portfolio?

PortView shows GRPH's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Graphite Bio (GRPH) Stock Analysis

NASDAQHealthcareBiotechnology

$3.18-2.75%

1-year price historyRange $15.26 – $26.11

52-week range$3.18

$3.05$29.82

What Graphite Bio does

Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.

Key metrics

Market cap

$185.19M

P/E (TTM)

-0.21

EPS (TTM)

$-15.33

Beta

0.20

Dividend yield

0.00%

Revenue / share

$0.68

50-day avg

$21.30

200-day avg

$18.24

52-week high

$29.82

52-week low

$3.05

CEO

Kimberlee Cobleigh Drapkin CPA

ETFs linked to GRPH

Broad-market and Healthcare sector ETFs an investor holding Graphite Bio is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how GRPH fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze GRPH in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Graphite Bio?: Graphite Bio trades under the ticker GRPH on NASDAQ.
Which exchange is GRPH listed on?: GRPH is listed on NASDAQ.
What sector does Graphite Bio operate in?: Graphite Bio is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze GRPH in a portfolio?: PortView shows GRPH's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.